TreeWAS – Variant ID: rs72845883

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
# Top node	1.000	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	1.000	0.000
Chapter II Neoplasms	1.000	0.000
Chapter XX External causes of morbidity and mortality	0.996	0.004
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.996	0.004
Chapter XXI Factors influencing health status and contact with health services	0.994	0.006
Chapter XII Diseases of the skin and subcutaneous tissue	0.994	0.006
Chapter XI Diseases of the digestive system	0.990	0.010
C60-C63 Malignant neoplasms of male genital organs	0.986	0.014
K55-K64 Other diseases of intestines	0.984	0.016
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.983	0.017
D70-D77 Other diseases of blood and blood-forming organs	0.983	0.017
D10-D36 Benign neoplasms	0.983	0.017
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.981	0.019
K56 Paralytic ileus and intestinal obstruction without hernia	0.979	0.021
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.979	0.021
Chapter XIV Diseases of the genitourinary system	0.976	0.024
C61 Malignant neoplasm of prostate	0.974	0.026
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.972	0.028
D70 Agranulocytosis	0.969	0.031
D69 Purpura and other haemorrhagic conditions	0.967	0.033
Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.966	0.034
N80-N98 Noninflammatory disorders of female genital tract	0.963	0.037
Chapter IX Diseases of the circulatory system	0.961	0.039
D60-D64 Aplastic and other anaemias	0.960	0.040
I95-I99 Other and unspecified disorders of the circulatory system	0.959	0.041
Z00-Z13 Persons encountering health services for examination and investigation	0.958	0.042
I95 Hypotension	0.957	0.043
D69.6 Thrombocytopenia, unspecified	0.950	0.050
Z08 Follow-up examination after treatment for malignant neoplasm	0.947	0.053
I95.9 Hypotension, unspecified	0.946	0.054
L40-L45 Papulosquamous disorders	0.944	0.056
D37-D48 Neoplasms of uncertain or unknown behaviour	0.942	0.058
K56.5 Intestinal adhesions [bands] with obstruction	0.935	0.065
Z70-Z76 Persons encountering health services in other circumstances	0.933	0.067
Y43 Primarily systemic agents	0.933	0.067
Y83.2 Surgical operation with anastomosis, bypass or graft	0.932	0.068
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.930	0.070
N30-N39 Other diseases of urinary system	0.929	0.071
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.928	0.072
L80-L99 Other disorders of the skin and subcutaneous tissue	0.924	0.076
D64 Other anaemias	0.922	0.078
N84 Polyp of female genital tract	0.921	0.079
Chapter VII Diseases of the eye and adnexa	0.917	0.083
L40 Psoriasis	0.917	0.083
Chapter VIII Diseases of the ear and mastoid process	0.910	0.090
T81 Complications of procedures, not elsewhere classified	0.908	0.092
K56.7 Ileus, unspecified	0.908	0.092
L60-L75 Disorders of skin appendages	0.906	0.094
Y43.3 Other antineoplastic drugs	0.905	0.095
N85 Other noninflammatory disorders of uterus, except cervix	0.903	0.097
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.903	0.097
K56.6 Other and unspecified intestinal obstruction	0.902	0.098
I95.1 Orthostatic hypotension	0.901	0.099
N80 Endometriosis	0.899	0.101
Y83.8 Other surgical procedures	0.899	0.101
N35 Urethral stricture	0.897	0.103
D64.9 Anaemia, unspecified	0.896	0.104
L40.9 Psoriasis, unspecified	0.896	0.104
Z72 Problems related to lifestyle	0.893	0.107
H02 Other disorders of eyelid	0.887	0.113
K65-K67 Diseases of peritoneum	0.887	0.113
Chapter XV Pregnancy, childbirth and the puerperium	0.881	0.119
Y83.6 Removal of other organ (partial) (total)	0.879	0.121
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.878	0.122
N35.9 Urethral stricture, unspecified	0.874	0.126
T81.8 Other complications of procedures, not elsewhere classified	0.873	0.127
S80-S89 Injuries to the knee and lower leg	0.859	0.141
K55 Vascular disorders of intestine	0.859	0.141
S60-S69 Injuries to the wrist and hand	0.857	0.143
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.855	0.145
L72 Follicular cysts of skin and subcutaneous tissue	0.850	0.150
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.847	0.153
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.845	0.155
N10-N16 Renal tubulo-interstitial diseases	0.844	0.155
Chapter XXII Codes for special purposes	0.841	0.159
K60 Fissure and fistula of anal and rectal regions	0.840	0.160
H02.3 Blepharochalasis	0.839	0.161
D23 Other benign neoplasms of skin	0.839	0.161
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.838	0.162
T15-T19 Effects of foreign body entering through natural orifice	0.836	0.164
Chapter I Certain infectious and parasitic diseases	0.836	0.164
N84.1 Polyp of cervix uteri	0.833	0.167
L82 Seborrhoeic keratosis	0.833	0.167
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.831	0.169
D32 Benign neoplasm of meninges	0.829	0.171
D50-D53 Nutritional anaemias	0.828	0.171
H90-H95 Other disorders of ear	0.823	0.177
L81 Other disorders of pigmentation	0.822	0.177
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.821	0.179
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.818	0.182
K70-K77 Diseases of liver	0.818	0.182
D22 Melanocytic naevi	0.818	0.182
Z72.1 Alcohol use	0.817	0.183
C15-C26 Malignant neoplasms of digestive organs	0.815	0.185
L72.1 Trichilemmal cyst	0.814	0.186
H02.4 Ptosis of eyelid	0.812	0.188
T88 Other complications of surgical and medical care, not elsewhere classified	0.811	0.189
N30 Cystitis	0.811	0.189
N84.0 Polyp of corpus uteri	0.810	0.190
N88 Other noninflammatory disorders of cervix uteri	0.810	0.190
C51-C58 Malignant neoplasms of female genital organs	0.800	0.199
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.800	0.200
Z72.0 Tobacco use	0.798	0.202
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.796	0.204
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.794	0.206
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.792	0.208
N80.9 Endometriosis, unspecified	0.788	0.212
Z09 Follow-up examination after treatment for conditions other than malignant neoplasms	0.786	0.214
A30-A49 Other bacterial diseases	0.785	0.215
N85.4 Malposition of uterus	0.785	0.215
D13.1 Stomach	0.784	0.216
D69.3 Idiopathic thrombocytopenic purpura	0.784	0.216
D22.3 Melanocytic naevi of other and unspecified parts of face	0.784	0.216
K35-K38 Diseases of appendix	0.783	0.217
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.780	0.220
D68 Other coagulation defects	0.779	0.221
V20-V29 Motorcycle rider injured in transport accident	0.779	0.221
I99 Other and unspecified disorders of circulatory system	0.778	0.222
D21 Other benign neoplasms of connective and other soft tissue	0.778	0.222
D46 Myelodysplastic syndromes	0.777	0.223
N81 Female genital prolapse	0.777	0.223
D33 Benign neoplasm of brain and other parts of central nervous system	0.777	0.223
Y44 Agents primarily affecting blood constituents	0.776	0.224
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.774	0.226
K66 Other disorders of peritoneum	0.774	0.226
D10 Benign neoplasm of mouth and pharynx	0.772	0.228
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.770	0.230
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.768	0.232
D73 Diseases of spleen	0.767	0.232
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.767	0.233
Z22 Carrier of infectious disease	0.766	0.234
H00 Hordeolum and chalazion	0.766	0.234
D17 Benign lipomatous neoplasm	0.765	0.235
Z30-Z39 Persons encountering health services in circumstances related to reproduction	0.765	0.235
K59 Other functional intestinal disorders	0.763	0.237
I98 Other disorders of circulatory system in diseases classified elsewhere	0.763	0.237
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.761	0.239
T66-T78 Other and unspecified effects of external causes	0.760	0.240
O20-O29 Other maternal disorders predominantly related to pregnancy	0.760	0.240
H55-H59 Other disorders of eye and adnexa	0.757	0.243
N85.0 Endometrial glandular hyperplasia	0.757	0.243
N13 Obstructive and reflux uropathy	0.756	0.244
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.755	0.245
Y40 Systemic antibiotics	0.755	0.245
D62 Acute posthaemorrhagic anaemia	0.753	0.247
S40-S49 Injuries to the shoulder and upper arm	0.750	0.250
D14 Benign neoplasm of middle ear and respiratory system	0.750	0.250
C90 Multiple myeloma and malignant plasma cell neoplasms	0.749	0.251
D80-D89 Certain disorders involving the immune mechanism	0.749	0.251
C62 Malignant neoplasm of testis	0.748	0.252
Z80-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status	0.748	0.252
K58 Irritable bowel syndrome	0.747	0.253
A41 Other septicaemia	0.746	0.254
N90 Other noninflammatory disorders of vulva and perineum	0.745	0.255
T85 Complications of other internal prosthetic devices, implants and grafts	0.745	0.255
T81.4 Infection following a procedure, not elsewhere classified	0.744	0.256
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.743	0.257
S30 Superficial injury of abdomen, lower back and pelvis	0.743	0.257
K60.1 Chronic anal fissure	0.742	0.258
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.742	0.258
C43-C44 Melanoma and other malignant neoplasms of skin	0.741	0.259
Z90 Acquired absence of organs, not elsewhere classified	0.740	0.260
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.739	0.261
L81.4 Other melanin hyperpigmentation	0.738	0.262
Z04 Examination and observation for other reasons	0.737	0.263
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.733	0.267
Z02 Examination and encounter for administrative purposes	0.731	0.269
S90-S99 Injuries to the ankle and foot	0.731	0.269
N80.8 Other endometriosis	0.730	0.270
D47.2 Monoclonal gammopathy	0.730	0.270
C83 Diffuse non-Hodgkin's lymphoma	0.728	0.271
D63 Anaemia in chronic diseases classified elsewhere	0.728	0.272
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.726	0.273
L97 Ulcer of lower limb, not elsewhere classified	0.726	0.274
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.726	0.274
C20 Malignant neoplasm of rectum	0.725	0.275
N39 Other disorders of urinary system	0.725	0.275
M80-M85 Disorders of bone density and structure	0.724	0.276
K55.2 Angiodysplasia of colon	0.723	0.277
C91 Lymphoid leukaemia	0.723	0.277
N99-N99 Other disorders of the genitourinary system	0.721	0.279
I30-I52 Other forms of heart disease	0.721	0.279
K65 Peritonitis	0.721	0.279
I60-I69 Cerebrovascular diseases	0.720	0.280
C81 Hodgkin's disease	0.720	0.280
N84.2 Polyp of vagina	0.717	0.283
N85.9 Noninflammatory disorder of uterus, unspecified	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.717	0.283
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.717	0.283
C40-C41 Malignant neoplasms of bone and articular cartilage	0.717	0.283
D55-D59 Haemolytic anaemias	0.717	0.283
L92 Granulomatous disorders of skin and subcutaneous tissue	0.717	0.283
K20-K31 Diseases of oesophagus, stomach and duodenum	0.716	0.284
D11 Benign neoplasm of major salivary glands	0.715	0.285
S70-S79 Injuries to the hip and thigh	0.714	0.286
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.714	0.286
Y35-Y36 Legal intervention and operations of war	0.714	0.286
Y10-Y34 Event of undetermined intent	0.714	0.286
Y00-Y09 Assault	0.714	0.286
X85-X99 Assault	0.714	0.286
X58-X59 Accidental exposure to other and unspecified factors	0.714	0.286
X50-X57 Overexertion, travel and privation	0.714	0.286
X40-X49 Accidental poisoning by and exposure to noxious substances	0.714	0.286
X30-X39 Exposure to forces of nature	0.714	0.286
X20-X29 Contact with venomous animals and plants	0.714	0.286
X10-X19 Contact with heat and hot substances	0.714	0.286
X00-X09 Exposure to smoke, fire and flames	0.714	0.286
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.714	0.286
W75-W84 Other accidental threats to breathing	0.714	0.286
W65-W74 Accidental drowning and submersion	0.714	0.286
W50-W64 Exposure to animate mechanical forces	0.714	0.286
W20-W49 Exposure to inanimate mechanical forces	0.714	0.286
V98-V99 Other and unspecified transport accidents	0.714	0.286
V95-V97 Air and space transport accidents	0.714	0.286
V90-V94 Water transport accidents	0.714	0.286
V80-V89 Other land transport accidents	0.714	0.286
V70-V79 Bus occupant injured in transport accident	0.714	0.286
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.714	0.286
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.714	0.286
V40-V49 Car occupant injured in transport accident	0.714	0.286
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.714	0.286
V01-V09 Pedestrian injured in transport accident	0.714	0.286
T79-T79 Certain early complications of trauma	0.714	0.286
T33-T35 Frostbite	0.714	0.286
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.714	0.286
T26-T28 Burns and corrosions confined to eye and internal organs	0.714	0.286
T20-T25 Burns and corrosions of external body surface, specified by site	0.714	0.286
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.714	0.286
T00-T07 Injuries involving multiple body regions	0.714	0.286
S10-S19 Injuries to the neck	0.714	0.286
L50-L54 Urticaria and erythema	0.713	0.287
L10-L14 Bullous disorders	0.712	0.288
N36 Other disorders of urethra	0.712	0.288
H65-H75 Diseases of middle ear and mastoid	0.711	0.289
N80.2 Endometriosis of Fallopian tube	0.709	0.291
T84 Complications of internal orthopaedic prosthetic devices, implants and grafts	0.708	0.291
X60-X84 Intentional self-harm	0.708	0.292
T18 Foreign body in alimentary tract	0.707	0.293
C63 Malignant neoplasm of other and unspecified male genital organs	0.707	0.293
C60 Malignant neoplasm of penis	0.707	0.293
K64 Haemorrhoids and perianal venous thrombosis	0.705	0.294
D67 Hereditary factor IX deficiency	0.705	0.295
D66 Hereditary factor VIII deficiency	0.705	0.295
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.705	0.295
D31 Benign neoplasm of eye and adnexa	0.705	0.295
D30 Benign neoplasm of urinary organs	0.705	0.295
D29 Benign neoplasm of male genital organs	0.705	0.295
D28 Benign neoplasm of other and unspecified female genital organs	0.705	0.295
D26 Other benign neoplasms of uterus	0.705	0.295
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.705	0.295
D19 Benign neoplasm of mesothelial tissue	0.705	0.295
D16 Benign neoplasm of bone and articular cartilage	0.705	0.295
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.705	0.295
D34 Benign neoplasm of thyroid gland	0.705	0.295
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system	0.705	0.295
D74 Methaemoglobinaemia	0.705	0.295
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere	0.705	0.295
D71 Functional disorders of polymorphonuclear neutrophils	0.705	0.295
Z22.3 Carrier of other specified bacterial diseases	0.703	0.297
K56.4 Other impaction of intestine	0.702	0.298
K56.3 Gallstone ileus	0.702	0.298
K56.1 Intussusception	0.702	0.298
K56.0 Paralytic ileus	0.702	0.298
T87 Complications peculiar to reattachment and amputation	0.702	0.298
T86 Failure and rejection of transplanted organs and tissues	0.702	0.298
T80 Complications following infusion, transfusion and therapeutic injection	0.702	0.298
Z11 Special screening examination for infectious and parasitic diseases	0.701	0.299
H91 Other hearing loss	0.701	0.299
K90-K93 Other diseases of the digestive system	0.701	0.299
T83.0 Mechanical complication of urinary (indwelling) catheter	0.700	0.300
H10-H13 Disorders of conjunctiva	0.700	0.300
N80.1 Endometriosis of ovary	0.700	0.300
N88.2 Stricture and stenosis of cervix uteri	0.700	0.300
L00-L08 Infections of the skin and subcutaneous tissue	0.699	0.301
D72 Other disorders of white blood cells	0.699	0.301
I05-I09 Chronic rheumatic heart diseases	0.698	0.302
D23.3 Skin of other and unspecified parts of face	0.698	0.302
S82 Fracture of lower leg, including ankle	0.697	0.303
Y59 Other and unspecified vaccines and biological substances	0.697	0.303
Y58 Bacterial vaccines	0.697	0.303
Y57 Other and unspecified drugs and medicaments	0.697	0.303
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.697	0.303
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.697	0.303
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.697	0.303
Y53 Agents primarily affecting the gastro-intestinal system	0.697	0.303
Y52 Agents primarily affecting the cardiovascular system	0.697	0.303
Y50 Central nervous system stimulants, not elsewhere classified	0.697	0.303
Y49 Psychotropic drugs, not elsewhere classified	0.697	0.303
Y48 Anaesthetics and therapeutic gases	0.697	0.303
Y47 Sedatives, hypnotics and antianxiety drugs	0.697	0.303
Y46 Antiepileptics and anti-Parkinsonism drugs	0.697	0.303
Y41 Other systemic anti-infectives and antiparasitics	0.697	0.303
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.697	0.303
Z09.8 Follow-up examination after other treatment for other conditions	0.696	0.304
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.695	0.305
N86 Erosion and ectropion of cervix uteri	0.695	0.305
D12.5 Sigmoid colon	0.694	0.306
Z90.4 Acquired absence of other parts of digestive tract	0.694	0.306
D69.9 Haemorrhagic condition, unspecified	0.693	0.307
D69.8 Other specified haemorrhagic conditions	0.693	0.307
D69.5 Secondary thrombocytopenia	0.693	0.307
D69.4 Other primary thrombocytopenia	0.693	0.307
D69.2 Other nonthrombocytopenic purpura	0.693	0.307
D69.1 Qualitative platelet defects	0.693	0.307
D69.0 Allergic purpura	0.693	0.307
C71 Malignant neoplasm of brain	0.693	0.307
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.693	0.307
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.693	0.307
N39.4 Other specified urinary incontinence	0.693	0.307
Y83.5 Amputation of limb(s)	0.693	0.307
Y83.0 Surgical operation with transplant of whole organ	0.693	0.307
K66.0 Peritoneal adhesions	0.693	0.307
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level	0.692	0.307
Y83.9 Surgical procedure, unspecified	0.692	0.308
O00-O08 Pregnancy with abortive outcome	0.692	0.308
S20-S29 Injuries to the thorax	0.690	0.309
N98 Complications associated with artificial fertilisation	0.690	0.310
N91 Absent, scanty and rare menstruation	0.690	0.310
N82 Fistulae involving female genital tract	0.690	0.310
N96 Habitual aborter	0.690	0.310
D32.0 Cerebral meninges	0.689	0.311
Z85 Personal history of malignant neoplasm	0.689	0.311
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.689	0.311
S81 Open wound of lower leg	0.689	0.311
I00-I02 Acute rheumatic fever	0.689	0.311
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.688	0.312
I97 Postprocedural disorders of circulatory system, not elsewhere classified	0.688	0.312
M50-M54 Other dorsopathies	0.688	0.312
H02.9 Disorder of eyelid, unspecified	0.687	0.313
Z10 Routine general health check-up of defined subpopulation	0.687	0.313
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.687	0.313
K31 Other diseases of stomach and duodenum	0.686	0.314
I95.8 Other hypotension	0.686	0.314
I95.2 Hypotension due to drugs	0.686	0.314
I95.0 Idiopathic hypotension	0.686	0.314
D75 Other diseases of blood and blood-forming organs	0.685	0.314
Y51 Drugs primarily affecting the autonomic nervous system	0.685	0.315
N30.1 Interstitial cystitis (chronic)	0.684	0.316
L40.5 Arthropathic psoriasis	0.684	0.316
N85.1 Endometrial adenomatous hyperplasia	0.683	0.317
Z40-Z54 Persons encountering health services for specific procedures and health care	0.683	0.317
C18 Malignant neoplasm of colon	0.683	0.317
C92 Myeloid leukaemia	0.682	0.317
S64 Injury of nerves at wrist and hand level	0.682	0.318
H02.0 Entropion and trichiasis of eyelid	0.682	0.318
K56.2 Volvulus	0.681	0.319
H53-H54 Visual disturbances and blindness	0.681	0.319
V10-V19 Pedal cyclist injured in transport accident	0.681	0.319
Z92 Personal history of medical treatment	0.679	0.321
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.679	0.321
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.679	0.321
K25 Gastric ulcer	0.679	0.321
N97 Female infertility	0.678	0.322
D13.2 Duodenum	0.677	0.323
L44 Other papulosquamous disorders	0.676	0.323
L41 Parapsoriasis	0.676	0.323
L45 Papulosquamous disorders in diseases classified elsewhere	0.676	0.323
L42 Pityriasis rosea	0.676	0.323
N85.2 Hypertrophy of uterus	0.676	0.324
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.676	0.324
Z90.1 Acquired absence of breast(s)	0.676	0.324
D51 Vitamin B12 deficiency anaemia	0.676	0.324
N83.1 Corpus luteum cyst	0.676	0.324
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.675	0.325
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.675	0.325
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.675	0.325
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.675	0.325
D00-D09 In situ neoplasms	0.674	0.326
S66 Injury of muscle and tendon at wrist and hand level	0.673	0.327
T88.7 Unspecified adverse effect of drug or medicament	0.672	0.328
S62 Fracture at wrist and hand level	0.672	0.328
K31.8 Other specified diseases of stomach and duodenum	0.670	0.330
Z51 Other medical care	0.670	0.330
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.670	0.330
D47.3 Essential (haemorrhagic) thrombocythaemia	0.669	0.331
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.669	0.331
Z76 Persons encountering health services in other circumstances	0.669	0.331
Z75 Problems related to medical facilities and other health care	0.669	0.331
Z70 Counselling related to sexual attitude, behaviour and orientation	0.669	0.331
Y43.9 Primarily systemic agent, unspecified	0.669	0.331
Y43.8 Other primarily systemic agents, not elsewhere classified	0.669	0.331
Y43.6 Enzymes, not elsewhere classified	0.669	0.331
Y43.5 Acidifying and alkalising agents	0.669	0.331
Y43.4 Immunosuppressive agents	0.669	0.331
Y43.2 Antineoplastic natural products	0.669	0.331
Y43.1 Antineoplastic antimetabolites	0.669	0.331
Y43.0 Antiallergic and antiemetic drugs	0.669	0.331
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.669	0.331
Y60-Y69 Misadventures to patients during surgical and medical care	0.668	0.332
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.668	0.332
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.668	0.332
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.667	0.333
C95 Leukaemia of unspecified cell type	0.667	0.333
C94 Other leukaemias of specified cell type	0.667	0.333
C93 Monocytic leukaemia	0.667	0.333
C88 Malignant immunoproliferative diseases	0.667	0.333
C86 Other specified types of T/NK-cell lymphoma	0.667	0.333
C84 Peripheral and cutaneous T-cell lymphomas	0.667	0.333
D27 Benign neoplasm of ovary	0.667	0.333
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.666	0.334
N37 Urethral disorders in diseases classified elsewhere	0.666	0.334
N34 Urethritis and urethral syndrome	0.666	0.334
N33 Bladder disorders in diseases classified elsewhere	0.666	0.334
Y83.3 Surgical operation with formation of external stoma	0.666	0.334
B35-B49 Mycoses	0.666	0.334
Y84.8 Other medical procedures	0.665	0.335
D23.1 Skin of eyelid, including canthus	0.664	0.336
N10 Acute tubulo-interstitial nephritis	0.663	0.336
K55.9 Vascular disorder of intestine, unspecified	0.663	0.337
N30.9 Cystitis, unspecified	0.662	0.338
H60-H62 Diseases of external ear	0.662	0.338
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.662	0.338
L95 Vasculitis limited to skin, not elsewhere classified	0.662	0.338
L94 Other localised connective tissue disorders	0.662	0.338
L93 Lupus erythematosus	0.662	0.338
L89 Decubitus ulcer	0.662	0.338
L87 Transepidermal elimination disorders	0.662	0.338
L88 Pyoderma gangrenosum	0.662	0.338
L86 Keratoderma in diseases classified elsewhere	0.662	0.338
L84 Corns and callosities	0.662	0.338
L83 Acanthosis nigricans	0.662	0.338
L80 Vitiligo	0.662	0.338
D64.8 Other specified anaemias	0.661	0.339
D64.4 Congenital dyserythropoietic anaemia	0.661	0.339
D64.3 Other sideroblastic anaemias	0.661	0.339
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.661	0.339
D64.1 Secondary sideroblastic anaemia due to disease	0.661	0.339
D64.0 Hereditary sideroblastic anaemia	0.661	0.339
H92 Otalgia and effusion of ear	0.661	0.339
N84.9 Polyp of female genital tract, unspecified	0.661	0.339
N84.8 Polyp of other parts of female genital tract	0.661	0.339
N84.3 Polyp of vulva	0.661	0.339
D47.1 Chronic myeloproliferative disease	0.661	0.339
T81.2 Accidental puncture and laceration during a procedure, not elsewhere classified	0.661	0.339
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.660	0.340
D46.9 Myelodysplastic syndrome, unspecified	0.660	0.340
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.659	0.341
H00.0 Hordeolum and other deep inflammation of eyelid	0.658	0.342
K55.0 Acute vascular disorders of intestine	0.658	0.342
L85 Other epidermal thickening	0.658	0.342
H46-H48 Disorders of optic nerve and visual pathways	0.657	0.342
L40.8 Other psoriasis	0.657	0.343
L40.4 Guttate psoriasis	0.657	0.343
L40.3 Pustulosis palmaris et plantaris	0.657	0.343
L40.2 Acrodermatitis continua	0.657	0.343
L40.1 Generalised pustular psoriasis	0.657	0.343
L40.0 Psoriasis vulgaris	0.657	0.343
D52 Folate deficiency anaemia	0.657	0.343
K86 Other diseases of pancreas	0.657	0.343
Z12 Special screening examination for neoplasms	0.657	0.343
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.656	0.344
Z73 Problems related to life-management difficulty	0.655	0.345
N89 Other noninflammatory disorders of vagina	0.654	0.345
H80-H83 Diseases of inner ear	0.654	0.346
L71 Rosacea	0.654	0.346
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.653	0.347
H02.5 Other disorders affecting eyelid function	0.652	0.348
D24 Benign neoplasm of breast	0.652	0.348
Chapter V Mental and behavioural disorders	0.652	0.348
T81.9 Unspecified complication of procedure	0.651	0.349
T81.7 Vascular complications following a procedure, not elsewhere classified	0.651	0.349
T81.6 Acute reaction to foreign substance accidentally left during a procedure	0.651	0.349
T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure	0.651	0.349
T81.1 Shock during or resulting from a procedure, not elsewhere classified	0.651	0.349
O48 Prolonged pregnancy	0.651	0.349
H90 Conductive and sensorineural hearing loss	0.651	0.349
D17.6 Benign lipomatous neoplasm of spermatic cord	0.651	0.349
D36 Benign neoplasm of other and unspecified sites	0.650	0.350
L75 Apocrine sweat disorders	0.650	0.350
L74 Eccrine sweat disorders	0.650	0.350
L73 Other follicular disorders	0.650	0.350
L70 Acne	0.650	0.350
L68 Hypertrichosis	0.650	0.350
L67 Hair colour and hair shaft abnormalities	0.650	0.350
L66 Cicatricial alopecia [scarring hair loss]	0.650	0.350
L65 Other nonscarring hair loss	0.650	0.350
L64 Androgenic alopecia	0.650	0.350
L63 Alopecia areata	0.650	0.350
L62 Nail disorders in diseases classified elsewhere	0.650	0.350
D35 Benign neoplasm of other and unspecified endocrine glands	0.649	0.350
L91 Hypertrophic disorders of skin	0.648	0.352
N85.7 Haematometra	0.647	0.352
N85.6 Intra-uterine synechiae	0.647	0.352
N85.5 Inversion of uterus	0.647	0.352
N85.3 Subinvolution of uterus	0.647	0.352
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.647	0.353
H05 Disorders of orbit	0.647	0.353
H03 Disorders of eyelid in diseases classified elsewhere	0.647	0.353
K74 Fibrosis and cirrhosis of liver	0.646	0.354
A80-A89 Viral infections of the central nervous system	0.646	0.354
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.645	0.354
T84.1 Mechanical complication of internal fixation device of bones of limb	0.646	0.354
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.645	0.355
D32.9 Meninges, unspecified	0.645	0.355
U80 Agent resistant to penicillin and related antibiotics	0.645	0.355
N80.6 Endometriosis in cutaneous scar	0.644	0.355
N80.5 Endometriosis of intestine	0.644	0.355
N80.4 Endometriosis of rectovaginal septum and vagina	0.644	0.355

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations